ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,633.91
      1.02%
      US Tech 100
      20,116.40
      -0.01%
      Dow Jones
      39,721.36
      0.00%
      Brent Oil
      84.785
      -0.31%
      Bitcoin
      58,794.00
      1.80%
      Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NYSE
      6. Dr Reddys Laboratories Ltd (RDY)

      7. Dr Reddys Laboratories Ltd (RDY) News

      RDY

      Dr Reddys Laboratories (RDY)

      Dr Reddys Laboratories Ltd
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NYSE:RDY
      DateTimeSourceHeadlineSymbolCompany
      12:30PMiHub NewswireFeaturedECGI Holdings Enhances Board with Artificial Intelligence (AI) Expert Ahead of Allon Apparel Launch
      07/10/202411:12AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:RDYDr Reddys Laboratories Ltd
      06/26/202411:26AMBusiness WireDr. Reddy’s to Acquire Nicotinell and Related Portfolio in Significant Step Towards Building Global Consumer Healthcare BusinessNYSE:RDYDr Reddys Laboratories Ltd
      06/20/20241:55PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:RDYDr Reddys Laboratories Ltd
      06/20/20246:09AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:RDYDr Reddys Laboratories Ltd
      06/18/20248:54AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:RDYDr Reddys Laboratories Ltd
      06/14/20249:04AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:RDYDr Reddys Laboratories Ltd
      06/14/20246:16AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:RDYDr Reddys Laboratories Ltd
      06/13/20246:18AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:RDYDr Reddys Laboratories Ltd
      06/12/20245:05PMEdgar (US Regulatory)Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]NYSE:RDYDr Reddys Laboratories Ltd
      06/12/20241:04PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:RDYDr Reddys Laboratories Ltd
      06/10/20246:07AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:RDYDr Reddys Laboratories Ltd
      06/07/20242:45PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:RDYDr Reddys Laboratories Ltd
      06/07/202410:39AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:RDYDr Reddys Laboratories Ltd
      06/05/20248:35AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:RDYDr Reddys Laboratories Ltd
      06/04/20248:23AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:RDYDr Reddys Laboratories Ltd
      06/03/20245:22PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:RDYDr Reddys Laboratories Ltd
      06/03/20241:05PMBusiness WireAurigene Pharmaceutical Services Limited, a Global CRDMO, Announces the Opening of Its Biologics Facility Offering Process Development and Clinical Scale Manufacturing CapabilitiesNYSE:RDYDr Reddys Laboratories Ltd
      06/03/20246:07AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:RDYDr Reddys Laboratories Ltd
      05/31/20247:27AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:RDYDr Reddys Laboratories Ltd
      05/30/202411:20AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:RDYDr Reddys Laboratories Ltd
      05/30/202411:17AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:RDYDr Reddys Laboratories Ltd
      05/29/20246:18AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:RDYDr Reddys Laboratories Ltd
      05/28/20249:53AMBusiness WireDr. Reddy's Laboratories Announces the Appointment of Milan Kalawadia to CEO North AmericaNYSE:RDYDr Reddys Laboratories Ltd
      05/28/20247:57AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:RDYDr Reddys Laboratories Ltd
      05/24/20241:58PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:RDYDr Reddys Laboratories Ltd
      05/24/20241:16PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:RDYDr Reddys Laboratories Ltd
      05/22/20241:23PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:RDYDr Reddys Laboratories Ltd
      05/21/202410:59AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:RDYDr Reddys Laboratories Ltd
      05/21/202410:49AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:RDYDr Reddys Laboratories Ltd
       Showing the most relevant articles for your search:NYSE:RDY